Stuart Raetzman

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda.

AqueSys, Inc. is a clinical-stage medical device company that develops ocular implants that reduce intraocular pressure (IOP) associated with glaucoma. It focuses on commercializing implantable devices that will significantly improve the treatment of glaucoma. The company was founded by Charles E. Larsen in 2006 and is headquartered in Parsippany, NJ

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

eyeonics, Inc. designs, develops, manufactures and sells premium intraocular lenses. Its lenses are implantable devices that replace the natural lens in the human eye, typically after the natural lens has developed cataracts that can significantly impair vision. The firm's products are designed to both replace a cataractous lens and correct a refractive error. The company was founded by Andrew J. Corley and Stuart J. Cumming in 1998 and is headquartered in Aliso Viejo, CA.

Anda, Inc. operates as a online store that enables physicians and physician offices to order pharmaceuticals and medical supplies through the Internet. It distributes generic, brand, specialty and over-the-counter pharmaceutical products to retail independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics and physician offices. The company was founded in 1992 and is headquartered in Parsippany, NJ.

Technolas Perfect Vision GmbH develops and markets laser and surgical technology solutions. Its brands include TENEO 317 Laser, VICTUS Femtosecond Laser, ZYOPTIX Diagnostic Workstation, and ZYOPTIX Microkeratome. The company was founded in 2009 and is headquartered in Munich, Germany.

Galderma (UK) Ltd. provides dermatological solutions. It offers skin structure, ageing skin, dry skin, acne, psoriasis, onychomycosis, rosacea, and skin cancer solutions. The company was founded on February 14, 1962 and is headquartered in Watford, the United Kingdom.

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life. It offers the world's most comprehensive portfolio of eye health products and the proud that it is one of the oldest, best known and most respected healthcare brands in the world. The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with products available in more than 100 countries.

Volunteer Legal Services Project of Monroe County, Inc. was founded in 1981. The non-profit company provides legal services and is based in Rochester, NY.

DBL Holdings LLC provides financial services. The private company is based in New York, NY. The company was founded by Ira Scott Greenspan.

AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.

Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.

Part of AbbVie, Inc., Forest Laboratories LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in New York, NY.

Visionary Ventures Management LLC (Visionary Ventures) is a venture capital firm founded in 2016 by Ehsan Sadri. The firm is headquartered in Aliso Viejo, California.

BELKIN Vision Ltd. provides glaucoma laser treatment. The company was founded by Michael Belkin in 2013 and is headquartered in Tel Aviv, Israel.

CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA.

Aviana Molecular Technologies LLC develops technologies for point of care diagnostic of infections. It develops a miniaturized biosensor capable of attaching to a smartphone or smart device through Bluetooth or other wireless connections. The company's diagnostic system is a diagnostic platform that can accurately, detect a target infectious disease, biomarkers or proteins in both clinical and scientific research settings. Its platform uses the latest developments in cellular communications, semiconductor electronics, micro-fluidics and manufacturing methods to create a unique point-of-care diagnostic platform to detect biomarkers or infections. The company was founded by Vanaja Ragavan in 2008 and is headquartered in Orlando, FL.

Flying L Management LLC (Flying L Management) is a venture capital firm founded in 2016. The firm is headquartered in Newport beach, California.

Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA.

Tear Film Innovations, Inc. engages in the research and development of products for the treatment of evaporative dry eye and related syndromes. It offers iLux system, a handheld treatment device which enables eye care professionals to identify and treat blocked meibomian glands. The company was founded by Kabir Gambhir and Brian Kelleher in 2014 and is headquartered in San Diergo, CA.

Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.

Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.

TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA.

Iantrek Inc provides biotechnology services. The company is headquartered in White Plains, NY.

Neurolens, Inc. is a company that commercializes breakthrough technology to improve vision care. The company's patented contoured prism technology provides visual comfort for the nearly 65% of US adults who complain of headaches, neck/shoulder pain, and eyestrain when using digital devices, reading, or doing detail work. The company is based in Coppell, TX. Inspired by a breakthrough discovery linking optometry and neurology, Neurolens is unlocking a new dimension of vision care. The Neurolens contoured prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. The technology is only available to independent eye care providers. The company was founded in 2012 by Davis Corley, and Pierre Bertrand has been the CEO of the company since 2019.

Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021.